Mechanisms, risk factors, and management of acquired long qt syndrome: A comprehensive review

The Scientific World Journal

Volumn 2012, Issue , 2012, Pages

  Kallergis, Eleftherios M ^a   Goudis, Christos A ^a   Simantirakis, Emmanuel N ^a   Kochiadakis, George E ^a   Vardas, Panos E ^a  

^a UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANTIMALARIAL AGENT; ANTIPROTOZOAL AGENT; ARSENIC TRIOXIDE; BUTYROPHENONE; CALCIUM; CHLOROQUINE; CHLORPROMAZINE; CISAPRIDE; CLARITHROMYCIN; CYTOCHROME P450 3A4; DISOPYRAMIDE; DOFETILIDE; ERYTHROMYCIN; HALOPERIDOL; IBUTILIDE; MACROLIDE; MAGNESIUM; MAGNESIUM SULFATE; METHADONE; PENTAMIDINE; PHENOTHIAZINE; POTASSIUM CHANNEL; POTASSIUM CHANNEL BLOCKING AGENT; PROCAINAMIDE; QUINIDINE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SOTALOL; THIORIDAZINE; VERAPAMIL;

ARRHYTHMOGENESIS; ARTICLE; BRADYCARDIA; CONGESTIVE HEART FAILURE; DRUG BLOOD LEVEL; ELECTROCARDIOGRAPHY; ELECTROLYTE DISTURBANCE; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE HYPERTROPHY; HEART PACING; HEART RATE; HEART REPOLARIZATION; HUMAN; HYPOKALEMIA; HYPOMAGNESEMIA; LONG QT SYNDROME; QRS COMPLEX; QT INTERVAL; QT PROLONGATION; RISK FACTOR; TORSADE DES POINTES; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; DRUG THERAPY; FEMALE; MALE; PATHOPHYSIOLOGY; REVIEW; SEX DIFFERENCE;

DRUG THERAPY; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; LONG QT SYNDROME; MALE; RISK FACTORS; SEX FACTORS; TORSADES DE POINTES;

EID: 84861050859     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1100/2012/212178     Document Type: Article

References (86)

1. Selzer A., Wray H. W., Quinidine syncope. Paroxysmal ventricular fibrillation occurring during treatment of chronic atrial arrhythmias Circulation 1964 30 17 26
2. Dessertenne F., Ventricular tachycardia with 2 variable opposing foci Archives des Maladies du Coeur et des Vaisseaux 1966 59 2 263 272
3. Lasser K. E., Allen P. D., Woolhandler S. J., Himmelstein D. U., Wolfe S. M., Bor D. H., Timing of new black box warnings and withdrawals for prescription medications Journal of the American Medical Association 2002 287 17 2215 2220 (Pubitemid 34441937)
4. Sadanaga T., Sadanaga F., Yao H., Fujishima M., An evaluation of ECG leads used to assess QT prolongation Cardiology 2006 105 3 149 154
5. Indik J. H., Pearson E. C., Fried K., Woosley R. L., Bazett and Fridericia QT correction formulas interfere with measurement of drug-induced changes in QT interval Heart Rhythm 2006 3 9 1003 1007 (Pubitemid 44283697)
6. Reardon M., Malik M., QT interval change with age in an overtly healthy older population Clinical Cardiology 1996 19 12 949 952 (Pubitemid 26404418)
7. Surawicz B., Knilans T., Chou T.-C., Chous Electrocardiography in Clinical Practice 2001 Philadelphia, Pa, USA W.B. Saunders Company
8. Morganroth J., Brozovich F. V., McDonald J. T., Jacobs R. A., Variability of the QT measurement in healthy men, with implications for selection of an abnormal QT value to predict drug toxicity and proarrhythmia American Journal of Cardiology 1991 67 8 774 776
9. Molnar J., Zhang F., Weiss J., Ehlert F. A., Rosenthal J. E., Diurnal pattern of QTc interval: how long is prolonged? Possible relation to circadian triggers of cardiovascular events Journal of the American College of Cardiology 1996 27 1 76 83
10. Sanguinetti M. C., Jurkiewicz N. K., Two components of cardiac delayed rectifier K+ current: differential sensitivity to block by class III antiarrhythmic agent Journal of General Physiology 1990 96 1 195 215 (Pubitemid 20227082)
11. Sanguinetti M. C., Jurkiewicz N. K., Delayed rectifier outward K+ current is composed of two currents in guinea pig atrial cells American Journal of PhysiologyHeart and Circulatory Physiology 1991 260 2 H393 H399
12. Gintant G. A., Two components of delayed rectifier current in canine atrium and ventricle: does IKs play a role in the reverse rate dependence of class III agents? Circulation Research 1996 78 1 26 37
13. Sanguinetti M. C., Kurkiewicz N. K., Scott A., Siegl P. K. S., Isoproterenol antagonizes prolongation of refractory period by the class III antiarrhythmic agent E-4031 in guinea pig myocytes: mechanism of action Circulation Research 1991 68 1 77 84
14. Jurkiewicz N. K., Sanguinetti M. C., Rate-dependent prolongation of cardiac action potentials by a methanesulfonanilide class III antiarrhythmic agent: Specific block of rapidly activating delayed rectifier K+ current by dofetilide Circulation Research 1993 72 1 75 83
15. Sanguinetti M. C., Curran M. E., Zou A., Shen J., Spector P. S., Atkinson D. L., Keating M. T., Coassembly of K(V)LQT1 and minK (IsK) proteins to form cardiac I(Ks) potassium channel Nature 1996 384 6604 80 83 (Pubitemid 26374592)
16. Barhanin J., Lesage F., Guillemare E., Fink M., Lazdunski M., Romey G., K(V)LQT1 and IsK (minK) proteins associate to form the I(Ks) cardiac potassium current Nature 1996 384 6604 78 80 (Pubitemid 26374591)
17. Roden D. M., Viswanathan P. C., Genetics of acquired long QT syndrome The Journal of Clinical Investigation 2005 115 2025 2032. A comprehensive review of molecular and cellular mechanisms underlying acquired LQTS (Pubitemid 41134138)
18. Curran M. E., Splawski I., Timothy K. W., Vincent G. M., Green E. D., Keating M. T., A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome Cell 1995 80 5 795 803
19. Sanguinetti M. C., Tristani-Firouzi M., hERG potassium channels and cardiac arrhythmia Nature 2006 440 463 469. Expert review of the role of KCNH2 in arrhythmias, in both congenital and drug induced LQTS
20. Fernandez D., Ghanta A., Kauffman G. W., Sanguinetti M. C., Physicochemical Features of the hERG Channel Drug Binding Site Journal of Biological Chemistry 2004 279 11 10120 10127 (Pubitemid 38372616)
21. Roden D. M., Lazzara R., Rosen M., Schwartz P. J., Towbin J., Michael Vincent G., Multiple mechanisms in the long-QT syndrome: current knowledge, gaps, and future directions Circulation 1996 94 8 1996 2012 (Pubitemid 26349316)
22. Antzelevitch C., Role of transmural dispersion of repolarization in the genesis of drug-induced torsades de pointes Heart Rhythm 2005 2 11 S9 S15
23. Yap Y. G., Camm A. J., Drug induced QT prolongation and torsades de pointes Heart 2003 89 11 1363 1372 (Pubitemid 37311108)
24. Swerdlow C. D., Martin D. J., Kass R. M., Davie S., Mandel W. J., Gang E. S., Chen P. S., The zone of vulnerability to T wave shocks in humans Journal of Cardiovascular Electrophysiology 1997 8 2 145 154 (Pubitemid 27085877)
25. Hii J. T. Y., Wyse D. G., Gillis A. M., Duff H. J., Solylo M. A., Mitchell L. B., Precordial QT interval dispersion as a marker of torsade de pointes: disparate effects of class Ia antiarrhythmic drugs and amiodarone Circulation 1992 86 5 1376 1382
26. Shah R. R., Drug-induced QT dispersion: does it predict the risk of torsade de pointes? Journal of Electrocardiology 2005 38 1 10 18 (Pubitemid 40127171)
27. Antzelevitch C., Tpeak-Tend interval as an index of transmural dispersion of repolarization European Journal of Clinical Investigation 2001 31 7 555 557 (Pubitemid 32642882)
28. Antzelevitch C., Role of spatial dispersion of repolarization in inherited and acquired sudden cardiac death syndromes American Journal of PhysiologyHeart and Circulatory Physiology 2007 293 4 H2024 H2038
29. Antzelevitch C., Heterogeneity and cardiac arrhythmias: an overview Heart Rhythm 2007 4 7 964 972 (Pubitemid 46959206)
30. Topilski I., Rogowski O., Rosso R., Justo D., Copperman Y., Glikson M., Belhassen B., Hochenberg M., Viskin S., The morphology of the QT interval predicts torsade de pointes during acquired bradyarrhythmias Journal of the American College of Cardiology 2007 49 3 320 328 (Pubitemid 46110956)
31. Yamaguchi M., Shimizu M., Ino H., Terai H., Uchiyama K., Kotaro O., Mabuchi T., Konno T., Kaneda T., Mabuchi H., T wave peak-to-end interval and QT dispersion in acquired long QT syndrome: a new index for arrhythmogenicity Clinical Science 2003 105 6 671 676 (Pubitemid 38002357)
32. Xia Y., Liang Y., Kongstad O., Liao Q., Holm M., Olsson B., Yuan S., In vivo validation of the coincidence of the peak and end of the T wave with full repolarization of the epicardium and endocardium in swine Heart Rhythm 2005 2 2 162 169 (Pubitemid 40220820)
33. Emori T., Antzelevitch C., Cellular basis for complex T waves and arrhythmic activity following combined IKr and IKs block Journal of Cardiovascular Electrophysiology 2001 12 12 1369 1378 (Pubitemid 34073216)
34. Grabowski M., Karpinski G., Filipiak K. J., Opolski G., Images in cardiovascular medicine. Drug-induced long-QT syndrome with macroscopic T-wave alternans Circulation 2004 110 18 459 460
35. Shimizu W., Antzelevitch C., Cellular and ionic basis for T-wave alternans under long-QT conditions Circulation 1999 99 11 1499 1507 (Pubitemid 29140918)
36. Kirchhof P., Franz M. R., Bardai A., Wilde A. M., Giant T-U waves precede torsades de pointes in long QT syndrome. A systematic electrocardiographic analysis in patients with acquired and congenital QT prolongation Journal of the American College of Cardiology 2009 54 2 143 149
37. Hinterseer M., Thomsen M. B., Beckmann B. M., Pfeufer A., Schimpf R., Wichmann H. E., Steinbeck G., Vos M. A., Kaab S., Beat-to-beat variability of QT intervals is increased in patients with drug-induced long-QT syndrome: a case control pilot study European Heart Journal 2008 29 2 185 190
38. Roden D. M., Woosley R. L., Primm R. K., Incidence and clinical feature of the quinidine-associated long QT syndrome: implications for patient care American Heart Journal 1986 111 6 1088 1093 (Pubitemid 16085013)
39. Makkar R. R., Fromm B. S., Steinman R. T., Meissner M. D., Lehmann M. H., Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs Journal of the American Medical Association 1993 270 21 2590 2597 (Pubitemid 23346699)
40. Rautaharju P., Zhou S. H., Wong S., Calhoun H. P., Berenson G. S., Prineas R., Davignon A., Sex differences in the evolution of the electrocardiographic QT interval with age Canadian Journal of Cardiology 1992 8 7 690 695
41. Arya A., Gender-related differences in ventricular repolarization: beyond gonadal steroids Journal of Cardiovascular Electrophysiology 2005 16 5 525 527 (Pubitemid 40632485)
42. Yang T., Snyders D. J., Roden D. M., Rapid inactivation determines the rectification and [K+](o) dependence of the rapid component of the delayed rectifier K+ current in cardiac cells Circulation Research 1997 80 6 782 789 (Pubitemid 27230052)
43. Numaguchi H., Johnson J. P. Jr., Petersen C. I., Balser J. R., A sensitive mechanism for cation modulation of potassium current Nature Neuroscience 2000 3 5 429 430 (Pubitemid 30495621)
44. Yang T., Roden D. M., Extracellular potassium modulation of drug block of IKr: implications for torsade de pointes and reverse use-dependence Circulation 1996 93 3 407 411
45. Choy A. M., Lang C. C., Chomsky D. M., Rayos G. H., Wilson J. R., Roden D. M., Normalization of acquired QT prolongation in humans by intravenous potassium Circulation 1997 96 7 2149 2154 (Pubitemid 27425816)
46. Etheridge S. P., Compton S. J., Tristani-Firouzi M., Mason J. W., A new oral therapy for long QT syndrome: long-term oral potassium improves repolarization in patients with HERG mutations Journal of the American College of Cardiology 2003 42 10 1777 1782 (Pubitemid 37433657)
47. Roden D. M., Anderson M. E., The pause that refreshes, or does it? Mechanisms in torsades de pointes Heart 2000 84 3 235 237
48. Locati E. H., Maison-Blanche P., Dejode P., Cauchemez B., Coumel P., Spontaneous sequences of onset of torsade de pointes in patients with acquired prolonged repolarization: quantitative analysis of Holter recordings Journal of the American College of Cardiology 1995 25 7 1564 1575
49. Darbar D., Harris P., Hardy A., Marked steepening of QT restitution following cardioversion of atrial fibrillation Heart Rhythm 2004 1 S192
50. Choy A. M. J., Darbar D., Dell'Orto S., Roden D. M., Exaggerated QT prolongation after cardioversion of atrial fibrillation Journal of the American College of Cardiology 1999 34 2 396 401
51. Torp-Pedersen C., Mller M., Bloch-Thomsen P. E., Kber L., Sande E., Egstrup K., Agner E., Carlsen J., Videbk J., Marchant B., Camm A. J., Dofetilide in patients with congestive heart failure and left ventricular dysfunction The New England Journal of Medicine 1999 341 12 857 865 (Pubitemid 29427047)
52. Wyse K. R., Ye V., Campbell T. J., Action potential prolongation exhibits simple dose-dependence for sotalol, but reverse dose-dependence for quinidine and disopyramide: implications for proarrhythmia due to triggered activity Journal of Cardiovascular Pharmacology 1993 21 2 316 322 (Pubitemid 23027610)
53. Drouin E., Lande G., Charpentier F., Amiodarone reduces transmural heterogeneity of repolarization in the human heart Journal of the American College of Cardiology 1998 32 4 1063 1067 (Pubitemid 28459600)
54. Hohnloser S. H., Klingenheben T., Singh B. N., Amiodarone-associated proarrhythmic effects. A review with special reference to torsade de pointes tachycardia Annals of Internal Medicine 1994 121 7 529 535
55. Vorperian V. R., Havighurst T. C., Miller S., January C. T., Adverse effects of low dose amiodarone: a meta-analysis Journal of the American College of Cardiology 1997 30 3 791 801 (Pubitemid 27397663)
56. Lazzara R., Antiarrhythmic drugs and torsade de pointes European Heart Journal 1993 14 88 92 (Pubitemid 23352280)
57. Ellenbogen K. A., Stambler B. S., Wood M. A., Efficacy of intravenous inbutilide for rapid termination of atrial fibrillation and atrial flutter: a dose-response study Journal of the American College of Cardiology 1996 28 4 130 136 (Pubitemid 26266632)
58. Stambler B. S., Wood M. A., Ellenbogen K. A., Perry K. T., Wakefield L. K., VanderLugt J. T., Efficacy and safety of repeated intravenous doses of ibutilide for rapid conversion of atrial flutter or fibrillation. Ibutilide Repeat Dose Study Investigators Circulation 1996 94 7 1613 1621 (Pubitemid 26320266)
59. Zhang S., Zhou Z., Gong Q., Makielski J. C., January C. T., Mechanism of block and identification of the verapamil binding domain to HERG potassium channels Circulation Research 1999 84 9 989 998 (Pubitemid 29227678)
60. Shimizu W., Ohe T., Kurita T., Kawade M., Arakaki Y., Aihara N., Kamakura S., Kamiya T., Shimomura K., Effects of verapamil and propranolol on early afterdepolarizations and ventricular arrhythmias induced by epinephrine in congenital long QT syndrome Journal of the American College of Cardiology 1995 26 5 1299 1309
61. Aiba T., Shimizu W., Inagaki M., Noda T., Miyoshi S., Ding W. G., Zankov D. P., Toyoda F., Matsuura H., Horie M., Sunagawa K., Cellular and ionic mechanism for drug-induced long QT syndrome and effectiveness of verapamil Journal of the American College of Cardiology 2005 45 2 300 307 (Pubitemid 40094741)
62. Napolitano C., Schwartz P. J., Brown A. M., Ronchetti E., Bianchi L., Pinnavaia A., Acquaro G., Priori S. G., Evidence for a cardiac ion channel mutation underlying drug-induced QT prolongation and life-threatening arrhythmias Journal of Cardiovascular Electrophysiology 2000 11 6 691 696 (Pubitemid 30397542)
63. Yang P., Kanki H., Drolet B., Yang T., Wei J., Viswanathan P. C., Hohnloser S. H., Shimizu W., Schwartz P. J., Stanton M., Murray K. T., Norris K., George A. L., Roden D. M., Allelic variants in long-QT disease genes in patients with drug-associated torsades de pointes Circulation 2002 105 16 1943 1948 (Pubitemid 34437622)
64. Priori S. G., Napolitano C., Schwartz P. J., Low penetrance in the long-QT syndrome clinical impact Circulation 1999 99 4 529 533 (Pubitemid 29061868)
65. Priori S. G., Schwartz P. J., Napolitano C., Bloise R., Ronchetti E., Grillo M., Vicentini A., Spazzolini C., Nastoli J., Bottelli G., Folli R., Cappelletti D., Risk stratification in the long-QT syndrome The New England Journal of Medicine 2003 348 19 1866 1874 (Pubitemid 36532312)
66. Kannankeril P. J., Roden D. M., Norris K. J., Whalen S. P., George A. L., Murray K. T., Genetic susceptibility to acquired long QT syndrome: pharmacologic challenge in first-degree relatives Heart Rhythm 2005 2 2 134 140 (Pubitemid 40220815)
67. Roden D. M., Taking the idio out of idiosyncratic: predicting torsades de pointes Pacing and Clinical Electrophysiology 1998 21 5 1029 1034
68. Paulussen A. D. C., Gilissen R. A. H. J., Armstrong M., Doevendans P. A., Verhasselt P., Smeets H. J. M., Schulze-Bahr E., Haverkamp W., Breithardt G., Cohen N., Aerssens J., Genetic variations of HCNQ1, KCNH2, SCN5A, KCNE1, and KCNE2 in drug-induced long QT syndrome patients Journal of Molecular Medicine 2004 82 3 182 188 (Pubitemid 38392168)
69. Mank-Seymour A. R., Richmond J. L., Wood L. S., Reynolds J. M., Fan Y. T., Warnes G. R., Milos P. M., Thompson J. F., Association of torsades de pointes with novel and known single nucleotide polymorphisms in long QT syndrome genes American Heart Journal 2006 152 6 1116 1122 (Pubitemid 44854804)
70. Jost N., Virag L., Bitay M., Restricting excessive cardiac action potential and QT prolongation: a vital role for I Ks in human ventricular muscle Circulation 2005 112 1392 1399 (Pubitemid 41291763)
71. Silva J., Rudy Y., Subunit interaction determines I Ks participation in cardiac repolarization and repolarization reserve Circulation 2005 112 10 1384 1391 (Pubitemid 41291762)
72. Sanguinetti M. C., Kurkiewicz N. K., Scott A., Siegl P. K. S., Isoproterenol antagonizes prolongation of refractory period by the class III antiarrhythmic agent E-4031 in guinea pig myocytes: mechanism of action Circulation Research 1991 68 1 77 84
73. Habuchi Y., Tanaka H., Furukawa T., Tsujimura Y., Takahashi H., Yoshimura M., Endothelin enhances delayed potassium current via phospholipase C in guinea pig ventricular myocytes American Journal of PhysiologyHeart and Circulatory Physiology 1992 262 2 345 354
74. Xiao L., Xiao J., Luo X., Lin H., Wang Z., Nattel S., Feedback remodeling of cardiac potassium current expression: a novel potential mechanism for control of repolarization reserve Circulation 2008 118 10 983 992
75. Splawski I., Timothy K. W., Tateyama M., Clancy C. E., Malhotra A., Beggs A. H., Cappuccio F. P., Sagnella G. A., Kass R. S., Keating M. T., Variant of SCN5A sodium channel implicated in risk of cardiac arrhythmia Science 2002 297 5585 1333 1336 (Pubitemid 34913168)
76. Ackerman M. J., Tester D. J., Jones G. S., Will M. L., Burrow C. R., Curran M. E., Ethnic differences in cardiac potassium channel variants: implications for genetic susceptibility to sudden cardiac death and genetic testing for congenital long QT syndrome Mayo Clinic Proceedings 2003 78 12 1479 1487 (Pubitemid 37475631)
77. Koo S. H., Ho W. F., Lee E. J. D., Genetic polymorphisms in KCNQ1, HERG, KCNE1 and KCNE2 genes in the Chinese, Malay and Indian populations of Singapore British Journal of Clinical Pharmacology 2006 61 3 301 308 (Pubitemid 43382629)
78. Bezzina C. R., Shimizu W., Yang P., Koopmann T. T., Tanck M. W. T., Miyamoto Y., Kamakura S., Roden D. M., Wilde A. A. M., Common sodium channel promoter haplotype in Asian subjects underlies variability in cardiac conduction Circulation 2006 113 3 338 344 (Pubitemid 43803194)
79. Fitzgerald P. T., Ackerman M. J., Drug-induced torsades de pointes: the evolving role of pharmacogenetics Heart Rhythm 2005 2 11 S30 S37
80. Nguyen P. T., Scheinman M. M., Seger J., Polymorphous ventricular tachycardia: clinical characterization, therapy, and the QT interval Circulation 1986 74 2 340 349 (Pubitemid 16072129)
81. Vukmir R. B., Stein K. L., Torsades de pointes therapy with phenytoin Annals of Emergency Medicine 1991 20 2 198 200
82. Banai S., Tzivoni D., Drug therapy for torsade de pointes Journal of Cardiovascular Electrophysiology 1993 4 2 206 210 (Pubitemid 23144198)
83. Khan I. A., Clinical and therapeutic aspects of congenital and acquired long QT syndrome American Journal of Medicine 2002 112 1 58 66 (Pubitemid 34113856)
84. Damiano B. P., Rosen M. R., Effects of pacing on triggered activity induced by early afterdepolarizations Circulation 1984 69 5 1013 1025 (Pubitemid 14137298)
85. Viskin S., Torsades de pointes Current Treatment Options in Cardiovascular Medicine 1999 1 187 195
86. Viskin S., Cardiac pacing in the long QT syndrome: review of available data and practical recommendations Journal of Cardiovascular Electrophysiology 2000 11 5 593 600 (Pubitemid 30304814)